AFM
STAB

Anson Funds Management’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Anson Funds Management’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-28,773
Closed -$164K – 73
2014
Q4 		$164K Buy
+28,773
New +$225K 0.19% 67

Other funds holding STAB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
WA
Winfield Associates Cleveland, Ohio $276M AUM 15.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Anson Funds Management's STAB Position: Q1 2015 in Review

Anson Funds Management sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2015, closing a stake of 28,773 shares — an estimated $164K sold.

Anson Funds Management first reported a position in STAB in Q4 2014 and held it in 1 quarter. The position peaked at $164K in Q4 2014. 22 funds tracked by Wall St. Rank hold STAB as of Q1 2015.

  • Anson Funds Management reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • Anson Funds Management sold 28,773 Statera Biopharma, Inc. Common Stock shares in Q1 2015, an estimated $164K.
  • Anson Funds Management first reported a position in Statera Biopharma, Inc. Common Stock in Q4 2014 and held it in 1 quarter.
  • Anson Funds Management's Statera Biopharma, Inc. Common Stock position peaked at $164K in Q4 2014.
  • 22 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2015.

Based on Anson Funds Management's 13F filing for Q1 2015, filed 15 May 2015.